Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 478-900-1 | CAS number: 6156-18-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
2,2 -bis(methylthio) propane is of low toxicity in rats by the oral, dermal, and inhalation routes.
Oral route
The acute oral toxicity of 2,2 -bis(methylthio) propane was evaluated in rats according to OECD guideline 423 (Rokh, 2007a). 2,2 -bis(methylthio) propane was prepared in corn oil and was administered by oral route (gavage), under a volume of 10 mL/kg, to groups of three or six fasted female Sprague-Dawley rats at dose levels of 300 and 2000 mg/kg bw, respectively. Clinical signs, mortality and body weight gain were checked for a period of 14 days following the single administration of the test item. All animals were subjected to necropsy. At the dose-level of 300 mg/kg, no mortality and no clinical signs were observed. At the dose-level of 2000 mg/kg, no deaths occurred. On day 1, hypoactivity or sedation, lateral decubitus, piloerection and/or dyspnea, were observed in 5/6 females. Decubitus without any response to the external stimuli was noted in 2/6 animals. No other clinical signs were observed thereafter. The body weight gain of the treated animals was similar to that of laboratory historical control animals. At necropsy, no apparent abnormalities were observed in any animal. The oral LD0 of 2,2 -bis(methylthio) propane was higher than 2000 mg/kg in rats.
Inhalation route
The acute inhalation toxicity of 2,2 -bis(methylthio) propane was evaluated in a study performed following the OECD guideline 403 (Schuler, 2008). A group of five male and five female Wistar was exposed by nose-only, flow-past inhalation to the test item at an analytically determined mean concentration of 20.2 mg/L air. All animals were observed for clinical signs and mortality during and following the inhalation exposure, i. e. over a 15-day observation period. Body weights were recorded prior to exposure on test day 1, and during the observation period on test days 4, 8 and 15. On day 15, all animals were sacrificed and necropsied. The ranges of vapor/aerosol concentration, temperature, relative humidity, oxygen content and airflow measured during the exposure were considered to be satisfactory for a study of this type. In addition, the test item was considered to be respirable to rats. All animals survived the scheduled observation period. Salivation, decreased activity, lateral recumbency and bradypnea were observed in all animals on the day of exposure. No symptoms were recorded during the observation period from test day 2 onwards. Transient effects on the body weight were noted in most animals between test days 1 and 4. No treatment-related macroscopical findings were recorded. The LC0 of 2,2 -bis(methylthio) propane was estimated to be greater than 20.2 mg/L air. There was no indication of relevant sex-related differences in toxicity of the test item.
Dermal route
The acute dermal toxicity of 2,2 -bis(methylthio) propane was evaluated in rats according to OECD guideline 402 (Pelcot, 2008). BMTP was applied to the skin of one group of ten Sprague-Dawley rats (five males and five females). The application was performed with the undiluted 2,2 -bis(methylthio) propane at the dose-level of 2000 mg/kg, taking into consideration that its specific gravity was 0.987 g/mL. 2,2 -bis(methylthio) propane was then covered by a semi-occlusive dressing for 24 hours. Clinical signs, mortality and body weight gain were checked for a period of 14 days following the single application of the test item. All animals were subjected to necropsy. No deaths and no systemic clinical signs were observed during the study. Crusts were noted in 1/5 male from day 6 until day 14. When compared to laboratory historical control animals, a slightly lower body weight gain was observed in 1/5 females between day 1 and day 8, without any relevant consequence at the end of the observation period. The body weight gain of the other animals was not affected by treatment with 2,2 -bis(methylthio) propane. No apparent abnormalities were observed at necropsy in any animal. The dermal LD0 of 2,2 -bis(methylthio) propane was equal to or higher than 2000 mg/kg in rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- yes
- Remarks:
- The relative humidity recorded in the animal room was sometimes outside of the target ranges specified in the Study plan. This minor deviation was not considered to have compromised the validity or integrity of the study.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France.
- Age at study initiation:c approximately 8 weeks old
- Weight at study initiation: 198 ± 9 g
- Fasting period before study: yes
- Housing: polycarbonate cages with stainless steel lid (48 cm x 27 cm x 20 cm).
- Diet : free access to SsniffR/M-H pelleted diet (SSNIFF Spezialdiäten GmbH, Soest, Germany)
- Water : Drinking water filtered by a FG Millipore membrane (0.22 micron) was provided ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 30 to 70
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: To: 21 December 2006 - 18 January 2007 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 and 200 mg/ml
- Amount of vehicle (if gavage): 10 ml/kg
- Justification for choice of vehicle: solubility - Doses:
- 300 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 3 or 6
- Control animals:
- no
- Details on study design:
- CLINICAL EXAMINATIONS
The single administration was performed in the morning of day 1; it was followed by a 14-day observation period.
- Clinical signs and mortality
The animals were observed frequently during the hours following administration of the test item, for detection of possible treatment-related clinical signs. Thereafter, observation of the animals was made at least once a day.
Type, time of onset and duration of clinical signs were recorded for each animal individually.
- Body weight
The animals were weighed individually just before administration of the test item on day 1 and then on days 8 and 15.
The body weight gain of the treated animals was compared to that of CIT control animals with the same initial body weight.
PATHOLOGY
- Sacrifice
On day 15, all animals were killed by carbon dioxide asphyxiation.
- Macroscopic necropsy examination
All study animals were subjected to a macroscopic examination as soon as possible after death.
After opening the thoracic and abdominal cavities, a macroscopic examination of the main organs (digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and any other organs with obvious abnormalities) was performed.
- Preservation of tissues
No organ samples were taken. - Statistics:
- Not appropriate
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Remarks on result:
- other: no mortality was observed
- Mortality:
- No mortality was observed
- Clinical signs:
- other: At the dose-level of 300 mg/kg, no mortality and no clinical signs were observed. At the dose-level of 2000 mg/kg, no deaths occurred. On day 1, hypoactivity or sedation, lateral decubitus, piloerection and/or dyspnea, were observed in 5/6 females.
- Gross pathology:
- Macroscopic examination of the main organs of the animals revealed no apparent abnormalities.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD0 of BISMETHYLTHIOPROPANE was higher than 2000 mg/kg in rats.
- Executive summary:
The acute oral toxicity of BISMETHYLTHIOPROPANE (BMTP) was evaluated in rats according to OECD guideline 423. BMTP was prepared in corn oil and was administered by oral route (gavage), under a volume of 10 mL/kg, to groups of three or six fasted female Sprague-Dawley rats at dose levels of 300 and 2000 mg/kg bw, respectively. Clinical signs, mortality and body weight gain were checked for a period of 14 days following the single administration of the test item. All animals were subjected to necropsy.At the dose-level of 300 mg/kg, no mortality and no clinical signs were observed. At the dose-level of 2000 mg/kg, no deaths occurred. On day 1, hypoactivity or sedation, lateral decubitus, piloerection and/or dyspnea, were observed in 5/6 females. Decubitus without any response to the external stimuli was noted in 2/6 animals. No other clinical signs were observed thereafter. The body weight gain of the treated animals was similar to that of laboratory historical control animals. At necropsy, no apparent abnormalities were observed in any animal. The oral LD0 of BISMETHYLTHIOPROPANE was higher than 2000 mg/kg in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP guideline study
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- EC directive 92/69/EEC, Part B.2 "Acute Toxicity (Inhalation)" OECD, No. 403
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Wölferstrasse 4, 4414 Füllinsdorf / Switzerland
- Age at study initiation:
Males: 8 weeks
Females: 9 weeks
- Weight at study initiation:
Males: 244.7 to 258.7 g
Females: 191.8 to 207.9 g
- Fasting period before study:
- Housing: In groups of up to five of the same sex in Makrolon® type-4 cages with wire mesh tops and standard softwood bedding
- Diet: ad libitum access to a pelleted standard Kliba-Nafag 3433 rat maintenance diet (Provimi Kliba AG, 4303 Kaiseraugst, Switzerland)
- Water: Tap-water ad libitum
- Acclimation period: five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 - 70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From 29-Apr-2008 To 14-May-2008 - Route of administration:
- other: inhalation: vapor and aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Inhalation by nose-only, flow-past exposure
- Method of holding animals in test chamber: The animals were confined separately in restrained tubes which were positioned radially around the flow-past, nose-only exposure chamber.
- Source and rate of air:
- Method of conditioning air:
- System of generating particulates/aerosols: The test aerosol was generated using a plastic nebulizer, Hospital model 950, New-York, U.S.A. connected to a syringe pump. The polyethylene injector inside model 950 of the Hospitak nebulizer was replaced by a stainless steel injector.
- Method of particle size determination: Particle size determination was not performed. Due to high level of evaporation of the test item such determinations were proved not to be feasible.
- Treatment of exhaust air:
- Temperature, humidity, pressure in air chamber: The relative humidity and temperature in the chamber was measured continuously during exposure using Rotaric Hygrometer I-20. The results are reported at 30 minute intervals from the start of exposure.
TEST ATMOSPHERE
- Brief description of analytical method used: Chemical determinations of aerosol concentration were performed by drawing the test aerosol through a HVLP-filter type loaded in a 47 mm in-line stainless steel filter sampling device connected to two wash-bottles placed in series each containing 80 mL of acetone, cooled in water ice. The determinations were performed four times during exposure. Each filter was put into appropriately labelled vials and covered with 5 mL acetone. The content of each wash-bottle was transferred into appropriate glass flasks, the wash-bottles were rinsed with acetone and the flasks made up to 100 mL with the rinsing and tightly closed. The filters and the content of the wash-bottles were forwarded at 2-8 °C in a cool box to the study scientist for the analytical laboratory and stored at 2-8 °C until analysis. Analysis of the samples was performed using a GC method coupled to a FID detector and quantified with the area under the peak..
- Samples taken from breathing zone: yes
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: Approximately half of the test item was in the vapour phase because it passed the filter and was trapped in the first wash bottle. Therefore, the determination of a MMAD was considered not to be feasible. Accordingly, the test item was considered to be respirable to rats since approximately half of the total amount was in the vapour phase.
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- see above
- Duration of exposure:
- 4 h
- Concentrations:
- 20.2 mg/L (analytical)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Observations
- Viability /Mortality
Observations for viability were recorded once before exposure on the day of exposure, once per hour during exposure, once after exposure on test day 1 and twice daily during the remainder of the observation period.
- Clinical Signs
Each animal was examined once per hour during exposure, once after exposure on test day 1 and once daily during the observation period.
- Body Weights
The body weight of each animal was recorded on test days 1 (before exposure), 4, 8 and 15 (before necropsy).
Pathology
- Necropsy
All animals were necropsied and descriptions of all macroscopic abnormalities were recorded. The lungs, trachea, larynx and the head containing the nasopharyngeal tissue and gross findings were collected from all animals and fixed in neutral phosphate-buffered 4% formaldehyde solution. The lungs were instilled with the fixative at a hydrostatic pressure of 30 cm. - Statistics:
- Not appropriate
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- >= 20.2 mg/L air
- Exp. duration:
- 4 h
- Remarks on result:
- other: No mortality was observed
- Mortality:
- All animals survived the scheduled observation period of 15 days.
- Clinical signs:
- other: During exposure, salivation, bradypnea and decreased spontaneous activity were noted in all animals. Additionally, after the end of exposure, lateral recumbency was noted. From test day 2 onwards, all animals were free from clinical signs until their sche
- Body weight:
- From test day 1 to test day 4, marginal to slight body weight loss was noted in two males and two females. In addition, reduced body weight gain was observed for the remaining males and 1 female. From test day 4 onwards, all animals showed a normal body weight development.
- Gross pathology:
- No treatment-related macroscopical findings were recorded.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LC0 of Bismethylthiopropane was estimated to be greater than 20.2 mg/L air (analytically determined mean aerosol concentration).
- Executive summary:
The acute inhalation toxicity of Bismethylthiopropane was evaluated in a study performed following the OECD guideline 403. A group of five male and five female Wistar was exposed by nose-only, flow-past inhalation to the test item at an analytically determined mean concentration ofv 20.2 mg/L air. All animals were observed for clinical signs and mortality during and following the inhalation exposure, i.e. over a 15-day observation period. Body weights were recorded prior to exposure on test day 1, and during the observation period on test days 4, 8 and 15. On day 15, all animals were sacrificed and necropsied. The ranges of aerosol concentration, temperature, relative humidity, oxygen content and airflow measured during the exposure were considered to be satisfactory for a study of this type. In addition, the test item was considered to be respirable to rats. All animals survived the scheduled observation period. Salivation, decreased activity, lateral recumbency and bradypnea were observed in all animals on the day of exposure. No symptoms were recorded during the observation period from test day 2 onwards. Transient effects on the body weight were noted in most animals between test days 1 and 4. No treatment-related macroscopical findings were recorded. The LC0 of Bismethylthiopropane was estimated to be greater than 20.2 mg/L air. There was no indication of relevant sex-related differences in toxicity of the test item.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 20 200 mg/m³ air
- Quality of whole database:
- GLP guideline study
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 8 weeks old
- Weight at study initiation: 364 ± 11 g for the males and 252 ± 8 g for the females
- Fasting period before study: no
- Housing: GR900 cages with stainless steel lid (405 cm x 355 cm x 230 cm)
- Diet: free access to SsniffR/M-H pelleted diet (SSNIFF Spezialdiäten GmbH, Soest, Germany)
- Water: drinking water filtered by a FG Millipore membrane (0.22 micron) was provided ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 30 to 70
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12
IN-LIFE DATES: 24 January 2008 - 07 February 2008 - Type of coverage:
- semiocclusive
- Vehicle:
- other: none
- Details on dermal exposure:
- The undiluted test item was applied at the dose-level of 2000 mg/kg, taking into consideration that its specific gravity was 0.987 g/mL. The volume of administration was therefore 2.03 mL/kg.
The test item was placed directly on an area of the skin representing approximately 10% of the total body surface of the animals, calculated according to Meeh's formula (1) (i.e. approximately 5 cm x 7 cm for the males and 5 cm x 6 cm for the females). A hydrophilic gauze pad was then applied to the skin.
The test item and the gauze pad were held in contact with the skin for 24 hours by means of an adhesive hypoallergenic aerated semi-occlusive dressing and a restraining bandage. This dressing prevented ingestion of the test item by the animals.
No residual test item was observed on removal of the dressing.
The dose applied to each animal was adjusted according to the body weight determined on the day of treatment. - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- CLINICAL EXAMINATIONS
- Clinical signs and mortality
The animals were observed frequently during the hours following administration of the test item, for detection of possible treatment-related clinical signs. Thereafter, observation of the animals was made at least once a day until day 15. Type, time of onset and duration of clinical signs were recorded for each animal individually. From day 2, any local cutaneous reaction was recorded.
- Body weight
The animals were weighed individually just before administration of the test item on day 1 and then on days 8 and 15.
The body weight gain of the treated animals was compared to that of CIT control animals with a similar initial body weight.
PATHOLOGY
- Sacrifice
On completion of the observation period, all animals were deeply anesthetized by an intra peritoneal injection of pentobarbital and killed by exsanguination.
- Macroscopic necropsy examination
All study animals were subjected to a macroscopic examination as soon as possible after death.
After opening the thoracic and abdominal cavities, a macroscopic examination of the main organs (digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and any other organs with obvious abnormalities) was performed.
- Preservation of tissues
No organ samples were taken. - Statistics:
- Not appropriate
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Remarks on result:
- other: (No mortality was observed)
- Mortality:
- No deaths occurred during the study.
- Clinical signs:
- other: No systemic clinical signs were observed during the study. Crusts were noted in 1/5 males from day 6 until day 14.
- Gross pathology:
- Macroscopic examination of the main organs of the animals revealed no apparent abnormalities.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD0 of Bismethylthiopropane was equal to or higher than 2000 mg/kg in rats.
- Executive summary:
The acute dermal toxicity of BISMETHYLTHIOPROPANE (BMTP) was evaluated in rats according to OECD guideline 402. BMTP was applied to the skin of one group of ten Sprague-Dawley rats (five males and five females). The application was performed with the undiluted BMTP at the dose-level of 2000 mg/kg, taking into consideration that its specific gravity was 0.987 g/mL. BMTP was then covered by a semi-occlusive dressing for 24 hours. Clinical signs, mortality and body weight gain were checked for a period of 14 days following the single application of the test item. All animals were subjected to necropsy. No deaths and no systemic clinical signs were observed during the study. Crusts were noted in 1/5 males from day 6 until day 14. When compared to laboratory historical control animals, a slightly lower body weight gain was observed in 1/5 females between day 1 and day 8, without any relevant consequence at the end of the observation period. The body weight gain of the other animals was not affected by treatment with BMTP. No apparent abnormalities were observed at necropsy in any animal. The dermal LD0 of BISMETHYLTHIOPROPANE was equal to or higher than 2000 mg/kg in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP guideline study
Additional information
Justification for classification or non-classification
According to REGULATION (EC) No 1272/2008 and the available acute toxicity data, 2,2 -bis(methylthio) propane don't warrant a classification for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.